30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Tilray Brands Inc (TLRY)

Track

Over the last 90 days, Tilray Brands Inc. has seen a net sell-off of $232,878.64 from insiders, with one director proposing a sale of $232,872.0. This contrasts with earlier periods showing significant insider buying from executives, including the CEO and CFO. The company's stock has experienced a 32.8% decline in the past 90 days.
Stock chart
Ticker: TLRY Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hopkinson David G.
2 sales — total 465,751 USD
Sale 21 Apr 2026
Value US$587,645.22 | Price 352.96 | Shares 13,264
Proposed sale 21 Apr 2026
Value US$4,568,944.98 | Price 217.61 | Shares 56,666
Buy 31 Jul 2025
Value US$3,980,671.02 | Price 390.04 | Shares 86,124
Buy 30 Jul 2025
Value US$100,105.50 | Price 0.61 | Shares 165,000
Buy 30 Jul 2025
Value US$19,939.20 | Price 0.60 | Shares 33,500
Buy 15 Nov 2024
Value US$35,360.00 | Price 1.36 | Shares 26,000
Buy 17 Jan 2024
Value US$20,500.00 | Price 2.05 | Shares 10,000
Buy 16 Jan 2024
Value US$14,256.00 | Price 1.98 | Shares 7,200
Buy 12 Jan 2024
Value US$10,098.00 | Price 1.87 | Shares 5,400
Buy 12 Jan 2024
Value US$37,400.00 | Price 1.87 | Shares 20,000
Buy 12 Jan 2024
Value US$100,956.00 | Price 1.88 | Shares 53,700
Planned sale 7 Nov 2022
Value US$1,322,755.00 | Price 3.78 | Shares 350,000
Planned sale 5 Oct 2022
Value US$1,018,395.00 | Price 2.91 | Shares 350,000
Planned sale 6 Sep 2022
Value US$1,128,015.00 | Price 3.22 | Shares 350,000
Planned sale 5 Aug 2022
Value US$1,369,095.00 | Price 3.91 | Shares 350,000
Planned sale 5 Jul 2022
Value US$1,081,675.00 | Price 3.09 | Shares 350,000
Planned sale 18 Jun 2021
Value US$6,874,040.00 | Price 17.19 | Shares 400,000
Planned sale 17 Jun 2021
Value US$7,186,640.00 | Price 17.97 | Shares 400,000
Sale 3 Jun 2021
Value US$467,942.64 | Price 19.64 | Shares 23,826
Sale 12 May 2021
Value US$1,318,980.00 | Price 14.82 | Shares 89,000
Planned sale 16 Dec 2020
Value US$22,000.00 | Price 10.00 | Shares 2,200
Planned sale 6 Nov 2020
Value US$24,902.92 | Price 11.71 | Shares 2,127
Planned sale 6 Nov 2020
Value US$1,274,093.44 | Price 10.72 | Shares 118,852
Planned sale 6 Nov 2020
Value US$1,483,372.68 | Price 9.96 | Shares 148,933
Planned sale 6 Nov 2020
Value US$1,170,922.09 | Price 9.00 | Shares 130,088
Planned sale 6 Nov 2020
Value US$48,120.00 | Price 10.00 | Shares 4,812
Planned sale 6 Nov 2020
Value US$44,233.20 | Price 10.05 | Shares 4,400
Planned sale 5 Nov 2020
Value US$986,969.34 | Price 7.76 | Shares 127,213
Planned sale 5 Nov 2020
Value US$1,986,598.61 | Price 7.28 | Shares 272,787
Planned sale 4 Nov 2020
Value US$2,415,200.00 | Price 6.04 | Shares 400,000
Planned sale 16 Oct 2020
Value US$2,238,560.00 | Price 5.60 | Shares 400,000
Planned sale 15 Oct 2020
Value US$2,243,160.00 | Price 5.61 | Shares 400,000
Planned sale 14 Oct 2020
Value US$2,331,320.00 | Price 5.83 | Shares 400,000
Planned sale 23 Sep 2020
Value US$2,443,300.00 | Price 4.89 | Shares 500,000
Planned sale 22 Sep 2020
Value US$2,567,050.00 | Price 5.13 | Shares 500,000
Planned sale 21 Sep 2020
Value US$2,504,800.00 | Price 5.01 | Shares 500,000
Planned sale 1 Sep 2020
Value US$32,195.00 | Price 6.44 | Shares 5,000
Planned sale 3 Aug 2020
Value US$549,421.44 | Price 7.27 | Shares 75,526
Planned sale 3 Aug 2020
Value US$2,034,176.16 | Price 7.28 | Shares 279,608
Planned sale 3 Aug 2020
Value US$36,370.00 | Price 7.27 | Shares 5,000
Planned sale 16 Jul 2020
Value US$897,025.25 | Price 7.69 | Shares 116,668
Planned sale 15 Jul 2020
Value US$905,246.49 | Price 7.76 | Shares 116,666
Planned sale 14 Jul 2020
Value US$865,300.06 | Price 7.42 | Shares 116,666
Planned sale 18 Jun 2020
Value US$958,870.96 | Price 8.22 | Shares 116,668
Planned sale 17 Jun 2020
Value US$937,632.98 | Price 8.04 | Shares 116,666
Planned sale 16 Jun 2020
Value US$973,204.44 | Price 8.34 | Shares 116,666
Planned sale 1 May 2020
Value US$926,993.89 | Price 7.38 | Shares 125,580
Planned sale 1 May 2020
Value US$702,228.50 | Price 7.38 | Shares 95,131
Planned sale 13 Feb 2020
Value US$1,627,590.00 | Price 16.28 | Shares 100,000
Planned sale 13 Jan 2020
Value US$57,121.91 | Price 17.34 | Shares 3,294
Planned sale 13 Jan 2020
Value US$1,123,344.11 | Price 16.74 | Shares 67,113
Planned sale 13 Jan 2020
Value US$459,304.08 | Price 15.52 | Shares 29,593
Planned sale 11 Dec 2019
Value US$1,829,540.00 | Price 18.30 | Shares 100,000
Planned sale 2 Dec 2019
Value US$17,832.96 | Price 19.81 | Shares 900
Planned sale 2 Dec 2019
Value US$143,585.88 | Price 19.05 | Shares 7,537
Planned sale 2 Dec 2019
Value US$607,244.25 | Price 19.05 | Shares 31,875
Planned sale 20 Jun 2019
Value US$200,024.40 | Price 50.01 | Shares 4,000
Planned sale 20 Jun 2019
Value US$196,900.00 | Price 50.00 | Shares 3,938
Planned sale 20 Jun 2019
Value US$33,359.60 | Price 50.01 | Shares 667
Planned sale 15 Apr 2019
Value US$517,200.00 | Price 51.72 | Shares 10,000
Planned sale 5 Apr 2019
Value US$210,160.72 | Price 61.04 | Shares 3,443
Sale 2 Apr 2019
Value US$179,032.99 | Price 63.78 | Shares 2,807
Sale 2 Apr 2019
Value US$1,209,923.67 | Price 63.78 | Shares 18,970
Planned sale 1 Apr 2019
Value US$198,417.60 | Price 64.80 | Shares 3,062
Planned sale 1 Apr 2019
Value US$423,304.20 | Price 64.14 | Shares 6,600
Planned sale 1 Apr 2019
Value US$2,150,192.64 | Price 63.08 | Shares 34,088
Planned sale 1 Apr 2019
Value US$119,233.03 | Price 64.73 | Shares 1,842
Planned sale 1 Apr 2019
Value US$2,077,351.58 | Price 63.84 | Shares 32,539
Planned sale 1 Apr 2019
Value US$3,325,547.77 | Price 63.03 | Shares 52,758
Planned sale 14 Mar 2019
Value US$2,112,816.00 | Price 70.43 | Shares 30,000
Planned sale 1 Mar 2019
Value US$932,315.52 | Price 82.14 | Shares 11,351
Planned sale 1 Mar 2019
Value US$608,759.24 | Price 81.67 | Shares 7,454
Planned sale 1 Mar 2019
Value US$1,160,734.80 | Price 80.40 | Shares 14,437
Planned sale 1 Mar 2019
Value US$4,284,272.53 | Price 79.49 | Shares 53,897
Planned sale 25 Feb 2019
Value US$71,442.00 | Price 79.38 | Shares 900
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-22 2026-04-21 S Sale
3.2
Hopkinson David G.
Non-Executive Director
13,264 +33.3%
352.96
US$587,645 		13,264 +33.3% 352.96 US$587,645
2026-04-21 2026-04-21 PrS Proposed sale
3.2
Hopkinson David G.

Director

Non-Executive Director
56,666
217.61
US$4,568,945 		56,666 217.61 US$4,568,945
2025-08-04 2025-07-31 B Purchase
4.1
Gendel Mitchell

Global General Counsel

Officer
86,124 -12.2%
390.04
US$3,980,671 		86,124 -12.2% 390.04 US$3,980,671
2025-07-30 2025-07-30 B Purchase
4.1
SIMON IRWIN D

President and CEO

Officer
165,000 +4.4%
0.61
US$100,106 		165,000 +4.4% 0.61 US$100,106
2025-07-30 2025-07-30 B Purchase
2.9
Merton Carl A

Chief Financial Officer

Officer
33,500 +4.4%
0.60
US$19,939 		33,500 +4.4% 0.60 US$19,939
2024-11-18 2024-11-15 B Purchase
2.9
Merton Carl A

Chief Financial Officer

Officer
26,000 +inf%
1.36
US$35,360 		26,000 +inf% 1.36 US$35,360
2024-01-18 2024-01-17 B Purchase
3.2
FALTISCHEK DENISE M

Chief Strategy Officer

Officer
10,000 +3.5%
2.05
US$20,500 		10,000 +3.5% 2.05 US$20,500
2024-01-16 2024-01-16 B Purchase
4.1
Gendel Mitchell

Global General Counsel

Officer
7,200 +3.8%
1.98
US$14,256 		7,200 +3.8% 1.98 US$14,256
2024-01-12 2024-01-12 B Purchase
4.1
Gendel Mitchell

Global General Counsel

Officer
5,400 +2.9%
1.87
US$10,098 		5,400 +2.9% 1.87 US$10,098
2024-01-12 2024-01-12 B Purchase
2.9
Merton Carl A

Chief Financial Officer

Officer
20,000 +inf%
1.87
US$37,400 		20,000 +inf% 1.87 US$37,400
2024-01-12 2024-01-12 B Purchase
4.1
SIMON IRWIN D

President and CEO

Officer
53,700 +2.7%
1.88
US$100,956 		53,700 +2.7% 1.88 US$100,956
2022-11-09 2022-11-07 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
350,000 -5.3%
3.78
US$1,322,755 		350,000 -5.3% 3.78 US$1,322,755
2022-10-07 2022-10-05 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
350,000 -5.1%
2.91
US$1,018,395 		350,000 -5.1% 2.91 US$1,018,395
2022-09-08 2022-09-06 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
350,000 -4.8%
3.22
US$1,128,015 		350,000 -4.8% 3.22 US$1,128,015
2022-08-09 2022-08-05 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
350,000 -4.6%
3.91
US$1,369,095 		350,000 -4.6% 3.91 US$1,369,095
2022-07-07 2022-07-05 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
350,000 -4.4%
3.09
US$1,081,675 		350,000 -4.4% 3.09 US$1,081,675
2021-06-24 2021-06-18 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
400,000 -4.2%
17.19
US$6,874,040 		400,000 -4.2% 17.19 US$6,874,040
2021-06-24 2021-06-17 PlS Planned sale
3.6
Kennedy Brendan
Non-Executive Director
400,000 -4.0%
17.97
US$7,186,640 		400,000 -4.0% 17.97 US$7,186,640
2021-06-07 2021-06-03 S Sale
3.3
Meiers James R.

Head of Canada

Officer
23,826 -100.0%
19.64
US$467,943 		23,826 -100.0% 19.64 US$467,943
2021-05-14 2021-05-12 S Sale
2.9
Merton Carl A

Chief Financial Officer

Officer
89,000 -34.5%
14.82
US$1,318,980 		89,000 -34.5% 14.82 US$1,318,980
2020-12-18 2020-12-16 PlS Planned sale
St.Clare Christine
Non-Executive Director
2,200 -10.6%
10.00
US$22,000 		2,200 -10.6% 10.00 US$22,000
2020-11-10 2020-11-06 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
2,127 -0.0%
11.71
US$24,903 		2,127 -0.0% 11.71 US$24,903
2020-11-10 2020-11-06 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
118,852 -1.2%
10.72
US$1,274,093 		118,852 -1.2% 10.72 US$1,274,093
2020-11-10 2020-11-06 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
148,933 -1.5%
9.96
US$1,483,373 		148,933 -1.5% 9.96 US$1,483,373
2020-11-10 2020-11-06 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
130,088 -1.3%
9.00
US$1,170,922 		130,088 -1.3% 9.00 US$1,170,922
2020-11-10 2020-11-06 PlS Planned sale
Dopp Rebekah
Non-Executive Director
4,812 -20.8%
10.00
US$48,120 		4,812 -20.8% 10.00 US$48,120
2020-11-10 2020-11-06 PlS Planned sale
St.Clare Christine
Non-Executive Director
4,400 -19.1%
10.05
US$44,233 		4,400 -19.1% 10.05 US$44,233
2020-11-06 2020-11-05 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
127,213 -1.3%
7.76
US$986,969 		127,213 -1.3% 7.76 US$986,969
2020-11-06 2020-11-05 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
272,787 -2.7%
7.28
US$1,986,599 		272,787 -2.7% 7.28 US$1,986,599
2020-11-06 2020-11-04 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
400,000 -3.8%
6.04
US$2,415,200 		400,000 -3.8% 6.04 US$2,415,200
2020-10-20 2020-10-16 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
400,000 -3.6%
5.60
US$2,238,560 		400,000 -3.6% 5.60 US$2,238,560
2020-10-19 2020-10-15 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
400,000 -3.5%
5.61
US$2,243,160 		400,000 -3.5% 5.61 US$2,243,160
2020-10-16 2020-10-14 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
400,000 -3.4%
5.83
US$2,331,320 		400,000 -3.4% 5.83 US$2,331,320
2020-09-25 2020-09-23 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
500,000 -12.3%
4.89
US$2,443,300 		500,000 -12.3% 4.89 US$2,443,300
2020-09-24 2020-09-22 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
500,000 -12.3%
5.13
US$2,567,050 		500,000 -12.3% 5.13 US$2,567,050
2020-09-23 2020-09-21 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
500,000 -12.3%
5.01
US$2,504,800 		500,000 -12.3% 5.01 US$2,504,800
2020-09-03 2020-09-01 PlS Planned sale
Greenwood Maryscott
Non-Executive Director
5,000 -23.4%
6.44
US$32,195 		5,000 -23.4% 6.44 US$32,195
2020-08-05 2020-08-03 PlS Planned sale
Auerbach Michael
Non-Executive Director
75,526 -100.0%
7.27
US$549,421 		75,526 -100.0% 7.27 US$549,421
2020-08-05 2020-08-03 PlS Planned sale
Auerbach Michael
Non-Executive Director
279,608 -50.4%
7.28
US$2,034,176 		279,608 -50.4% 7.28 US$2,034,176
2020-08-05 2020-08-03 PlS Planned sale
Greenwood Maryscott
Non-Executive Director
5,000 -20.7%
7.27
US$36,370 		5,000 -20.7% 7.27 US$36,370
2020-07-16 2020-07-16 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
116,668 -2.9%
7.69
US$897,025 		116,668 -2.9% 7.69 US$897,025
2020-07-16 2020-07-15 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
116,666 -2.8%
7.76
US$905,246 		116,666 -2.8% 7.76 US$905,246
2020-07-16 2020-07-14 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
116,666 -2.7%
7.42
US$865,300 		116,666 -2.7% 7.42 US$865,300
2020-06-18 2020-06-18 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
116,668 -2.7%
8.22
US$958,871 		116,668 -2.7% 8.22 US$958,871
2020-06-18 2020-06-17 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
116,666 -2.6%
8.04
US$937,633 		116,666 -2.6% 8.04 US$937,633
2020-06-18 2020-06-16 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
116,666 -2.5%
8.34
US$973,204 		116,666 -2.5% 8.34 US$973,204
2020-05-05 2020-05-01 PlS Planned sale
Auerbach Michael
Non-Executive Director
125,580 -24.6%
7.38
US$926,994 		125,580 -24.6% 7.38 US$926,994
2020-05-05 2020-05-01 PlS Planned sale
Auerbach Michael
Non-Executive Director
95,131 -15.7%
7.38
US$702,229 		95,131 -15.7% 7.38 US$702,229
2020-02-18 2020-02-13 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
100,000 -2.1%
16.28
US$1,627,590 		100,000 -2.1% 16.28 US$1,627,590
2020-01-15 2020-01-13 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
3,294 -0.1%
17.34
US$57,122 		3,294 -0.1% 17.34 US$57,122
2020-01-15 2020-01-13 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
67,113 -1.4%
16.74
US$1,123,344 		67,113 -1.4% 16.74 US$1,123,344
2020-01-15 2020-01-13 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director Large shareholder
29,593 -0.6%
15.52
US$459,304 		29,593 -0.6% 15.52 US$459,304
2019-12-13 2019-12-11 PlS Planned sale Kennedy Brendan

President and CEO

Executive Director
100,000 -39.5%
18.30
US$1,829,540 		100,000 -39.5% 18.30 US$1,829,540
2019-12-04 2019-12-02 PlS Planned sale Auerbach Michael Non-Executive Director
900 -2.1%
19.81
US$17,833 		900 -2.1% 19.81 US$17,833
2019-12-04 2019-12-02 PlS Planned sale Auerbach Michael Non-Executive Director
7,537 -14.9%
19.05
US$143,586 		7,537 -14.9% 19.05 US$143,586
2019-12-04 2019-12-02 PlS Planned sale Auerbach Michael Non-Executive Director
31,875 -100.0%
19.05
US$607,244 		31,875 -100.0% 19.05 US$607,244
2019-06-24 2019-06-20 PlS Planned sale
St.Clare Christine
4,000 -45.7%
50.01
US$200,024 		4,000 -45.7% 50.01 US$200,024
2019-06-24 2019-06-20 PlS Planned sale
Dopp Rebekah
3,938 -45.0%
50.00
US$196,900 		3,938 -45.0% 50.00 US$196,900
2019-06-24 2019-06-20 PlS Planned sale
Greenwood Maryscott
667 -7.6%
50.01
US$33,360 		667 -7.6% 50.01 US$33,360
2019-04-17 2019-04-15 PlS Planned sale
CASTANEDA MARK

CFO, Secretary, Treasurer
10,000 -54.9%
51.72
US$517,200 		10,000 -54.9% 51.72 US$517,200
2019-04-09 2019-04-05 PlS Planned sale
3.0
Pastorius Edward Wood JR

Chief Revenue Officer
3,443 -19.0%
61.04
US$210,161 		3,443 -19.0% 61.04 US$210,161
2019-04-03 2019-04-02 S Sale
3.0
Pastorius Edward Wood JR

Chief Revenue Officer
2,807 -13.4%
63.78
US$179,033 		2,807 -13.4% 63.78 US$179,033
2019-04-03 2019-04-02 S Sale
3.6
Kennedy Brendan

President and CEO

Executive Director
18,970 -8.9%
63.78
US$1,209,924 		18,970 -8.9% 63.78 US$1,209,924
2019-04-03 2019-04-01 PlS Planned sale
3.0
Pastorius Edward Wood JR

Chief Revenue Officer
3,062 -17.2%
64.80
US$198,418 		3,062 -17.2% 64.80 US$198,418
2019-04-03 2019-04-01 PlS Planned sale
3.0
Pastorius Edward Wood JR

Chief Revenue Officer
6,600 -27.1%
64.14
US$423,304 		6,600 -27.1% 64.14 US$423,304
2019-04-03 2019-04-01 PlS Planned sale
3.0
Pastorius Edward Wood JR

Chief Revenue Officer
34,088 -58.3%
63.08
US$2,150,193 		34,088 -58.3% 63.08 US$2,150,193
2019-04-03 2019-04-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
1,842 -1.1%
64.73
US$119,233 		1,842 -1.1% 64.73 US$119,233
2019-04-03 2019-04-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
32,539 -16.3%
63.84
US$2,077,352 		32,539 -16.3% 63.84 US$2,077,352
2019-04-03 2019-04-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
52,758 -20.9%
63.03
US$3,325,548 		52,758 -20.9% 63.03 US$3,325,548
2019-03-18 2019-03-14 PlS Planned sale
CASTANEDA MARK

CFO, Secretary, Treasurer
30,000 -78.5%
70.43
US$2,112,816 		30,000 -78.5% 70.43 US$2,112,816
2019-03-05 2019-03-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
11,351 -5.3%
82.14
US$932,316 		11,351 -5.3% 82.14 US$932,316
2019-03-05 2019-03-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
7,454 -3.4%
81.67
US$608,759 		7,454 -3.4% 81.67 US$608,759
2019-03-05 2019-03-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
14,437 -6.1%
80.40
US$1,160,735 		14,437 -6.1% 80.40 US$1,160,735
2019-03-05 2019-03-01 PlS Planned sale
3.6
Kennedy Brendan

President and CEO

Executive Director
53,897 -18.6%
79.49
US$4,284,273 		53,897 -18.6% 79.49 US$4,284,273
2019-02-27 2019-02-25 PlS Planned sale
CASTANEDA MARK

CFO, Secretary, Treasurer

Officer
900 -9.9%
79.38
US$71,442 		900 -9.9% 79.38 US$71,442
Explore more

More insider trading research around Tilray Brands Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America